Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
C. Mircea S. Tesileanu(Erasmus MC Cancer Institute), Pim J. French(Erasmus MC Cancer Institute), Paul M. Clément(Universitair Ziekenhuis Leuven), Maurice de Wit(Erasmus MC Cancer Institute), Anja Gijtenbeek(Radboud University Nijmegen), Warren Mason(Princess Margaret Cancer Centre), Martin J. van den Bent(Erasmus MC Cancer Institute), Anna K. Nowak(The University of Western Australia), Jaap C. Reijneveld(Amsterdam UMC Location University of Amsterdam), Catherine McBain(Unknown), Matthew Griffin(Nottingham University Hospitals NHS Trust), Michael Weller(University Hospital of Zurich), Sanjeev Gill(The Alfred Hospital), Lorenzo Boggiani(Erasmus MC Cancer Institute), Walter Taal(Heidelberg University), Iris de Heer(Erasmus MC Cancer Institute), Filip De Vos(University Medical Center Utrecht), Thierry Lesimple, Thierry Gorlia(European Organisation for Research and Treatment of Cancer), Roelien H. Enting(University of Groningen), Francesca Caparrotti(University Hospital of Geneva), Paul Mulholland(University College London Hospitals NHS Foundation Trust), Pieter Wesseling(Radboud University Nijmegen), Susan Clenton(Weston Park Cancer Centre), Sara Erridge(The University of Texas MD Anderson Cancer Center), Martin Taphoorn(Leiden University Medical Center), Robert B. Jenkins(Dartmouth–Hitchcock Medical Center), Jan Oosting(Leiden University Medical Center), Helen Wheeler(The University of Sydney), Ken Aldape(The University of Texas MD Anderson Cancer Center), Sanne Venneker(Leiden University Medical Center), Marc Sanson(Centre National de la Recherche Scientifique), Johan M. Kros(Erasmus MC), Olivier Chinot(Aix-Marseille Université), Leland Rogers(NRG Oncology), Brigitta G. Baumert(Kantonsspital Graubünden), Wolfgang Wick(German Cancer Research Center), Youri Hoogstrate(Erasmus MC), Judith V.M.G. Bovée(Leiden University Medical Center), Elizabeth Lim(Plymouth Hospital), Alba A. Brandes(Istituto delle Scienze Neurologiche di Bologna), Roberta Rudà, Jean Français Baurain(Cliniques Universitaires Saint-Luc), Vassilis Golfinopoulos(Champalimaud Foundation), Hendrikus J. Dubbink(Erasmus MC), Michael A. Vogelbaum(Moffitt Cancer Center), Wies Vallentgoed(Erasmus MC Cancer Institute)
Cited by 60
Related Papers
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
|Nature|2008|7.8k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Paraneoplastic anti– <i>N</i> ‐methyl‐ <scp>D</scp> ‐aspartate receptor encephalitis associated with ovarian teratoma
|Annals of Neurology|2007|2.5k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k